GET /trials/source/12/?page=2
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 380,
    "next": "http://api.gregory-ms.com/trials/source/12/?page=3",
    "previous": "http://api.gregory-ms.com/trials/source/12/",
    "results": [
        {
            "title": "Ocrelizuamb for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.",
            "summary": "<b>Conditions</b>:    Radiologically Isolated Syndrome;   Multiple Sclerosis<br/><b>Interventions</b>:    Drug: Ocrelizumab;   Other: Placebo<br/><b>Sponsors</b>:    Yale University;   Genentech, Inc.<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04877457?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-05-07T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-05-07T11:43:30Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br/><b>Intervention</b>:    Drug: Natalizumab<br/><b>Sponsor</b>:    Biogen<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05265728?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-03-03T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-03-03T12:52:45Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Iyengar Yoga;   Yoga;   EDSS<br/><b>Intervention</b>:    Other: The effect of Iyengar yoga practice on patients with multiple sclerosis<br/><b>Sponsor</b>:    University Hospital, Motol<br/><b>Active, not recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05247372?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-02-18T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-02-18T13:53:27Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Figure of 8 Walk Test in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Assesment<br /><b>Sponsor</b>:    Kahramanmaras Sutcu Imam University<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05433714?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-27T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-27T13:30:06.486520Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt",
            "summary": "<b>Condition</b>:    Relapsing-Remitting Multiple Sclerosis<br /><b>Intervention</b>:    Drug: Fingolimod<br /><b>Sponsor</b>:    Hikma Pharmaceuticals LLC<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05423769?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-20T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-21T14:30:07.076364Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Sensing Physical Activity to Evaluate and Monitor a Routine Aftercare Program (SensE-M)",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Disease With a Risk for Chronicity&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Zurich;   Kliniken Valens&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05243407?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-02-17T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-02-17T12:33:27Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: partial-body cryotherapy chamber session&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Fondation Ildys;   Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05219201?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-02-01T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-02-01T14:57:18Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Designing Virtual Reality-based Software for People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Exergaming<br /><b>Sponsors</b>:    Yuzuncu Yıl University;   Dokuz Eylul University<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05420532?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-15T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-15T11:10:05.936487Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Natalizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Biogen;   Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05236777?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-02-11T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-02-11T14:03:27Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Promoting Aerobic Training in Multiple Sclerosis",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Aerobic exercise;   Behavioral: Task-oriented upper-limb training;   Behavioral: Sport events participation&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Fondazione Italiana Sclerosi Multipla;   University of Genoa;   University Grenoble Alps&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05212805?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-01-28T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-01-28T15:57:18Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        }
    ]
}